ptosis is similar to apoptosis. However, erythrocytes lack nuclei and mitochondria, important organelles in the machinery executing apoptosis. Accordingly, erythrocytes lack several features of apoptosis including mitochondrial depolarization and condensation of nuclei. However, eryptosis shares several other features of apoptosis, such as cell shrinkage, membrane blebbing, and cell membrane scrambling, leading to phosphatidylserine exposure at the cell surface [1] .
In this review, mechanisms regulating, triggering, and inhibiting the suicidal erythrocyte death or eryptosis are briefly described. As only 30 references are allowed for this review, only the most recent papers on eryptosis are cited. Earlier references are available in a previous review [1] .
Mechanisms Triggering Eryptosis
Ca 2+ Eryptosis is elicited by an increase in cytosolic Ca 2+ activity [1] . Ca 2+ stimulates cell membrane scrambling and activates the cysteine endopeptidase calpain, an enzyme that degrades cytoskeletal proteins thus causing cell membrane blebbing [1] . Ca 2+ further activates Ca 2+ -sensitive K + channels with subsequent efflux of K + , hyperpolarization of the cell membrane, and Cl -exit due to enhanced electrical gradient. The cellular loss of KCl is followed by the exit of osmotically obliged water, thus leading to cell shrinkage [1] .
The increase in cytosolic Ca 2+ activity may result from activation of nonselective cation channels mediating Ca 2+ entry [1] . The molecular identity of the cation channels is incompletely understood, but presumably involves transient receptor potential channel 6 [1] . The cation channels are activated by a wide variety of challenges including osmotic shock, oxidative stress, and Cl -removal [1] . Hyperosmotic shock is affected at least in part by stimulation of cyclooxygenase with generation of prostaglandin E 2 , which in turn activates the cation channel [1] .
Ceramide
The Ca 2+ sensitivity of erythrocyte cell membrane scrambling and cell shrinkage is enhanced by ceramide, which similarly stimulates eryptosis [1] . Ceramide may be produced from cell membrane sphingomyelin by sphingomyelinase, which may either be expressed in erythrocytes or released into plasma and act from outside [1] . Ceramide formation may be stimulated by plateletactivating factor (PAF), which is in turn formed from cell membrane lipids by a phospholipase [1] . The phospholipase is activated and thus PAF released following osmotic erythrocyte shrinkage. Erythrocytes do express PAF receptors, and exposure of erythrocytes to PAF stimulates ceramide formation [1] . Gene-targeted mice lacking PAF receptors are insensitive to the effects of PAF on ceramide formation and eryptosis [1] .
Additional Mechanisms
A wide variety of further mechanisms and challenges participate in the triggering or regulation of eryptosis. Eryptosis is stimulated by energy depletion, which is at least partially affected by activation of protein kinase C [1] .
Eryptosis is further activated following oxidative stress or following impairment of antioxidative defense [1] . Oxidative stress activates the Ca 2+ -permeable cation channels, thus stimulating Ca 2+ entry. Oxidative stress further activates erythrocyte Cl -channels, which contributes to eryptotic cell shrinkage. In addition, oxidative stress activates caspases, which could stimulate eryptosis, but are not required for eryptosis following Ca 2+ entry [1] .
Eryptosis is regulated by a variety of kinases, such as cGMPdependent protein kinase type I, AMP-activated kinase, and Janus kinase 3 ( table 1 ). A powerful inhibitor of eryptosis is nitric oxide, which renders erythrocytes partially resistant against the eryptotic effects of increased cytosolic Ca 2+ activity ( table 2 ) .
Diseases Associated with Enhanced Eryptosis
Excessive eryptosis is observed in a variety of diseases ( table 1 ) . Several genetic defects of hemoglobin synthesis, such as sickle cell anemia and thalassemia; erythrocyte enzymes, such as glucose-6-phosphate dehydrogenase deficiency; or carriers, such as the anion exchanger 1, are associated with enhanced vulnerability of the erythrocytes against stimulators of eryptosis [1] . In one family with excessive eryptosis, a mutation of GLUT1 was observed, turning the glucose carrier into a Ca 2+ -permeable cation channel. More importantly, enhanced eryptosis is observed in common diseases, such as iron deficiency, diabetes, and renal insufficiency. As eryptosis is highly sensitive to temperature and triggered by hyperthermia ( table 2 ) , eryptosis is expected to occur in fever. Excessive eryptosis is observed in sepsis and in hemolytic uremic syndrome. Hemolytic disorders analyzed thus far have been shown to be paralleled by excessive eryptosis. It appears that hemolysis is only the tip of the iceberg and that in most affected erythrocytes parallel eryptosis prevents lysis with subsequent release of hemoglobin into the plasma [1] .
Eryptosis is triggered following invasion of the malaria pathogen Plasmodium. Following entry into the erythrocyte, the pathogen induces oxidative stress, which activates the Ca 2+ -permeable cation channels and thus triggers eryptosis. The suicidal death is followed by the clearance of the infected erythrocyte together with the pathogen, thus counteracting parasitemia. At least in mice, several substances triggering eryptosis have been found to favorably influence the clinical course of the disease [1] .
Enhanced eryptosis is observed in newly formed erythrocytes of healthy individuals returning from high altitudes or space flight, a phenomenon called 'neocytolysis'. The enhanced eryptosis in patients with paroxysmal nocturnal hemoglobinuria and myelodysplastic syndrome preferably affects lighter and, thus, presumably younger erythrocytes, pointing to neocytolysis in those diseases [2] . At this stage, the mechanisms underlying neocytolysis have remained elusive [1] . Notably, a similarly enhanced susceptibility to eryptosis is observed in erythrocytes drawn from erythropoietin-overexpressing transgenic mice [1] . Possibly, erythropoietin stimulates in progenitor cells the expression of genes sensitizing the erythrocytes to eryptotic challenges. As a result, erythrocytes undergo, in part, suicidal death as soon as the erythropoietin concentrations decline. The premature clearance of erythrocytes may serve to normalize blood erythrocyte concentration as soon as it is no longer needed and the plasma erythropoietin concentrations fall. Accordingly, neocytolysis may accelerate the negative feedback regulation of erythrocyte abundance, which otherwise would take 120 days. Additional experimental efforts are needed to prove or disprove this speculation.
Excessive eryptosis has also been observed in several gene-targeted mice, thus pointing to molecules involved in the regulation of erythrocyte survival ( table 1 ) . Similar to human disease, mice with defective hemoglobin (sickle cell, thalassemia) suffer from accelerated suicidal erythrocyte death. A mouse model resembling sickle cell anemia is the A7 mouse. Similar to sickle cell trait erythrocytes, A7-deficient erythrocytes generate excessive PGE 2 , which in turn activates the cation channels with subsequent eryptosis [3] . Eryptosis is inhibited by cGMPdependent protein kinase type I, AMP-activated protein kinase. Accordingly, gene-targeted mice lacking one of those kinases suffer from accelerated eryptosis. Similarly, endothelin inhibits ery ptosis, and mice lacking the endothelin B receptor suffer from accelerated eryptosis. Knockout of the anion exchanger 1 is followed by severely enhanced eryptosis and anemia despite excessive formation of new erythrocytes. As pointed out above, mice overexpressing erythropoietin harbor erythrocytes particularly sensitive to eryptosis. In Klotho deficiency, the excessive formation of 1,25(OH) 2 D 3 leads to moderately enhanced eryptosis. In adenomatous polyposis coli-deficient mice, the appearance of intestinal tumors is paralleled by increased eryptosis. In some mice, the erythrocytes may be resistant to specific stimulators of eryptosis, such as mice expressing decreased levels of phosphoinositide-dependent kinase 1 or mice lacking the PAF receptor or transient receptor potential channel 6 ( table 1 ). G6P D = Glucose-6-phosphate dehydrogenase; AE1 = anion exchanger 1; cGKI = cGMP-dependent protein kinase type I; AMPK = AMP-activated protein kinase; JAK3 = Janus kinase 3; APC = adenomatous polyposis coli; EPO = erythropoietin; PDK1 = phosphoinositide-dependent kinase 1; TRPC6 = transient receptor potential channel 6. Mechanisms: Ca 2+ = stimulation of Ca 2+ entry; Cer. = stimulation of ceramide formation; other = inhibition of ATP depletion, etc. To limit the number of references, preference is given to reviews. 
Consequences of Eryptosis
Phosphatidylserine-exposing erythrocytes are rapidly cleared from circulating blood. They bind to respective receptors of macrophages and are then engulfed and degraded [1] . As a result, excessive eryptosis leads to anemia unless the enhanced loss of erythrocytes is compensated by similarly enhanced formation of new erythrocytes. The formation of new erythrocytes is apparent from the percentage of reticulocytes. Thus, accelerated eryptosis may be apparent from reticulocytosis rather than anemia.
Phosphatidylserine-exposing erythrocytes further adhere to the vascular wall and may therefore impede microcirculation [1] . It is particularly intriguing to speculate that PGE 2 -stimulated excessive eryptosis leads to the breakdown of microcirculation in kidney medulla following acute renal failure.
Conclusions
Similar to apoptosis of nucleated cells, eryptosis is the suicidal death of mature erythrocytes. Eryptosis is accomplished by a complex machinery involving activation of ion channels, stimulation or inhibition of kinases, and formation of ceramide. Accelerated eryptosis is encountered in a wide variety of diseases and is stimulated by a large number of small molecules. Future experiments are expected to uncover additional triggers and inhibitors of eryptosis, as well as further signaling molecules contributing to the orchestration of the tightly regulated suicidal erythrocyte death.
